Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are complex procedures with a very steep a learning curve (LC). This study evaluates the LC of CRS and HIPEC in a single-center experience of peritoneal surface malignancies (PSMs). Approximately 140 to 150 cases were necessary for the acquisition of competence in CRS and HIPEC with adequate radicality and acceptable safety. Eighty to 100 cases were necessary to assure short-term prognostic gains in rare PSMs. This article highlights how LC and continuous monitoring of surgical performance is critical in evaluating the credibility of emerging and already established PSM centers
BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further...
Peritoneal surface malignancy (PM), regardless of the dissemination site, was once considered a term...
The reiteration of surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC...
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are complex proced...
Background: CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now t...
Background: CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now t...
Background: Peritoneal surface malignancies (PSMs) are a heterogenous group of primary and metastati...
ImportanceHyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have been show...
Abstract Background The goal of the study was to investigate the current clinical practices among on...
Experience with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in...
Background: Cytoreductive surgery (CRS) is a technically demanding procedure, and there is considera...
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has gained increas...
Copyright © 2011 Horacio N. López-Basave et al. This is an open access article distributed under th...
Cytoreductive surgery (CRS) associated with hyperthermic intra-peritoneal chemotherapy (HIPEC) repre...
Abstract Background Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cance...
BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further...
Peritoneal surface malignancy (PM), regardless of the dissemination site, was once considered a term...
The reiteration of surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC...
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are complex proced...
Background: CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now t...
Background: CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now t...
Background: Peritoneal surface malignancies (PSMs) are a heterogenous group of primary and metastati...
ImportanceHyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have been show...
Abstract Background The goal of the study was to investigate the current clinical practices among on...
Experience with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in...
Background: Cytoreductive surgery (CRS) is a technically demanding procedure, and there is considera...
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has gained increas...
Copyright © 2011 Horacio N. López-Basave et al. This is an open access article distributed under th...
Cytoreductive surgery (CRS) associated with hyperthermic intra-peritoneal chemotherapy (HIPEC) repre...
Abstract Background Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cance...
BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further...
Peritoneal surface malignancy (PM), regardless of the dissemination site, was once considered a term...
The reiteration of surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC...